TNFSF10 and cancer: Previous studies have shown that down-regulation of Mcl-1 by antisense oligonucleotides is sufficient to induce apoptosis in MM cells and to enhance cancer cell sensitivity to TRAIL, suggesting that Mcl-1 might be a potential therapeutic target for the treatment of several human malignancies, including MM [37,44].